Global Pharmaceuticals & Biotechnology Royalty Rates Report 2022 with Detailed Financial Information from Real-World Transactions
Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition" report has been added to ResearchAndMarkets.com's offering.
Royalty Rates for Pharmaceuticals & Biotechnology features more real-deal royalty rates, license fees, and milestone payment benchmarks than any other publication.
The ninth edition of Royalty Rates for Pharmaceuticals & Biotechnology contains hundreds of royalty rates and other financial compensation benchmarks that can be used to optimize the pricing of biotechnology and pharmaceutical innovations. You'll find updated and expanded information from past editions as well as an increased number of reported license agreements.
This new edition and the transaction details have been collected from well-established sources over a period of 22 years of research. Royalty Rates for Pharmaceuticals & Biotechnology provides real-deal information for hundreds of transactions, including the technology licensed, royalty rates, license fees, and milestone payments. And it goes well beyond the rates to provide context for each deal analyzed.
This unique resource is organized into two useful sections:
The first section covers the theory associated with deriving royalty rates.
An overview of intellectual property value is included along with seven methods that can be employed to derive royalty rates: Simple Rules of Thumb, Industry Guidelines, Discounted Cash Flow Analysis, Risk-Adjusted Net Present Value Analysis, Infringement Damages Analysis, Comparable License Transactions, Investment Rate of Return Analysis, and the Relief-From-Royalty Method.
The second section of this one-of-a-kind report presents detailed financial information from real-world transactions.
You'll find information on the parties involved in the transactions along with a description of the technology exchanged and all financial details that could be discovered. This publication is designed to provide accurate and authoritative information about the subject matter covered.
Key Topics Covered:
1,2-diphenylethanes, 1,3-diphenylpropanes and benzyl tetralins
Abuse Deterrent
Actimmune - interferon gamma-1b
Adult Growth Hormone Deficiency
Agriculture
Alcohol Dependency Treatment
Aldurazyme - recombinant form of the human enzyme alpha-L-iduronidase
Alpha Interferon - Natural
Alzheimer's Treatment
Alzheimer's Diagnostic Test
Anemia
Anesthetic
Animal Health Products
Antibiotic
Antibodies
Antifungal
Antifungal Agent - Amphotericin B
Anti-hypertension Therapy
Arginine Products
Arthritis - Rheumatoid - Drug Humira
Asthma Drug - Oral Administration
Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder Therapy
Autoimmune Disease Therapy
Automated Cell Processing Instrument
Automated Process Research
Bacterial Infections
BetaKine (TGF-beta-2)
Bicifadine
Biochemical Technology Portfolio
Blood
BPI - Human Protein
Cancer
Cancer Diagnostics
Cancer- Histone Deacetylase (HDAC) Inhibitors
Cancer LukemiaTreatment
Cancer Research Technology
Cancer Therapy
Cancer Treatment
Cannabinoid Receptor Meditating Compounds
Cardiorenal Disease Therapies
Cardiovascular
Cartilage Regenerative Technology
Catheter Technology
cdkl Assay
Cell Adhesion Technology - LEC-CAM
Cell Cultures
Chimeric IgG1 antibodies
Cholesterol High LDL Treatment
Cholesterol Treatment
Chromosome Analysis Technology
Chronic Obstructive Pulmonary Disease Therapy
Cochleates, Liposomes and Proteoliposomes
Cold Remedy
Collagenase Ointment
Consensus Interferon
Contraceptive
Contrast Agent - Intravenous
COPD Treatment
Coronary Drug-eluting Stent
Cough Medicine
Crohn's Disease Therapy
Cyclin Dependent Kinasc Assay Test Kit
Cypress Stem Cells
Cystic Fibrosis Treatment
Cytomegalovirus Intravenous Treatment
Deferrum deferiprone
Dermatology
Diabetes
Diagnostic Alliance
Diagnostic Imagining Using Ligands
Dietary Supplement - Botanical
Diltiazem Heart Drug
DNA - PK
DNA Binding Invention
DNA Nanocircles
DNA Synthesis
Drug Delivery
EGF Fusion Protein
Eli Lilly & Co. Experiences Compulsory License Royalty Rates
Enoxaparin
Environmental Test Kit
Enzyme Inhibitors
Epilepsy Treatment - ADCI
EPO, Hepatitis B and IL-2
Erectial Dsyfuction Therapy - VitarosT
Erythronmycin Antibiotic
Estrogen Replacement Therapy
Fertility Treatment
Fibrotic Disease Therapy - Pirfenidone
Financing Research
Fusion Inihibitors for HIV
Gastrointestinal Infection
Gastroretentive Drug Delivery Devices for Oral Intake
Gene Activation Technology
Gene Alteration Technology
Gene Sequencing
Gene Splicing Technology
Gene Therapy Partnership Network
Genetic Abnormalities Test - Prenatal
Genetic Research
Genetic Technology
Genetically Engineered Listeria Immune Therapy
Genomics-based Drug Discovery
Glycogen Storage Disease III
Hepatitis
Hereditary Angioedema
Hereditary ATTR (hATTR) amyloidosis.
HIV and AIDS
Human Gene Technology
Human Growth Hormone
Human Monoclonal Antibodies Discovery Technology
Human Monoclonal Antibodu - Adalimumab
Humanization Antibody
Humanized Antibody
Humanized Monoclonal Antibody
Hypertension Treatment- autologous gene therapy
Hypertension Treatment- tadalafil
Immune (idiopathic) Thrombocytopenic Purpura Therapy
Immune System Enhancement
Immune System Regulators - Cytokines
Immunodeficiency
Immunotoxin - MDX-RA
Indiplon
Infections - Bacterial
Infertility Treatment - Male
Inflammation Antibody-based Therapeutics
Inflammatory - Topical Therapy
Inflammatory Diseases
Influenza Drug
Inhaler Technology
Insomnia
Insomnia Therapy
Integrelin Drug
Interferon Gamma-1b
Intracellular Receptor Technology
Kidney Disease Treatment
Liver Disease Therapy
Living Cells Connective Tissue
Lubrin
Lung Problems (Emphysema) Treatment
Lupis Nephritis
Lupus Nephritis
Macular Degeneration Therapy
Macular Therapy - Spinal Muscular Atrophy
Mammary Cell Growth Inhibitor
Metabolic Treatment
Michellamine B/Tropical Vine Leaves
Microorganism Detection in Water
Microsponge Delivery System
Migraine Relief
Modulation of Opioid Receptors
Monoclonal Antibodies Binding to TGF-B
Monoclonal Antibodies to Gram Negative Sepsis-Related Bacteria
Monoclonal Antibody 45-J Test
Monoclonal Antibody Technology
mRNA Technology
Multiple Sclerosis
Multiple Sclerosis - Relasping
Multiple Sclerosis Therapy - Copaxone
Naked DNA Technology
Nanocrystalline Particles
NASA Technology
Nasal Decongestant
Nasal Vitamin B-12 Therapy
Natural Cell Signaling Phenomenon
Nerve Repair
Nervous System Therapeutics
NeuroCell Joint Venture
Neurodegenerative and Psychiatric Diseases Therapy
Neurological
Neurology - Menkes disease
Neurotrophic Factor Commercialization
Nicotine Addiction Treatment
Nifedipine Crystals
Novasome Lipid Vesicles Encapsulation Technology
Nuclear Matrix Protein Technology
Nucleic Acid
Nureologogical Disorders Anti-agitation Drug
Nutrition - Salt Alternative
Obesity
Obesity Therapy
Opthalmic
Oral Contraceptive
Osteoarthritis Treatment for Animals
Osteoporosis Compound 1-apiha-hydroxyvitamin D2
Oxygenation
Pain Management
Parkinson's Disease
PEG Enhanced L-asparaginase
Pegylated Reagent
Personal Care
Pet Medication
Photodynamic Therapy
Platinate HPMA Copolymer
Pneumocystis Carinii Pneumonia
Poly (ADP Ribose) Polymerase Diagnostic Assay
Polymerase Chain Reaction Technology
Pre-eclampsia/Toxemia Diagnosis and Therapy
Primary Biliary Cholangitis
Pro-Apolipoprotein A-I and Lipid Complexes
Progesterone Gel
Protein Secretion Technology
Proteomics Technology
Psychiatric & Psychotic Therapy
Psychotherapeutic Drugs
Pulmonary Disease
Radynilel Hypoxic Tumor Cell Radiosensitizer
Rapid Diagnostic Test
RAS Human Protein/Rational Drug Design
Recombinant Human Erythropoietin- Procrit
Recombinant Human Inerlukin-twelve (rhIL-1 2)
Recombinant Technology
Respiratory Therapy
Retinoids
Rhenium Radiotherapy and Monoclonal Antibodies
Ribozymes
Rickets - x-linked hypophosphatemia treatment
RNAi Interference Technology
RNAi Interference Therapies
Sarafem
Schizophrenia
Schizophrenia and Bipolar Treatment
Septic Shock Treatment - Human Thymosin beta 4 (T?4), a 43-amino acid peptide
Sexual Dysfunction Therapy
Skin Disorder
Skin Technology - Polyactive Polymer Biomaterial
Sleep Therapy
Spirulina
Spleen Tyrosine Kinase (Syk) Inhibitor
Stem Cell
Stem-loop Vector Technology
Stromal Derived Factor 1 (SDF-1) Peptide Agonists and Antagonists
Sugar Substitute
TamifluT
TelavancinT - Antibotic
Testosterone Replacement
TGF-beta
Thalidomide
Thalidomide Analogs
Thymidine Kinase Isoenzyme Diagnostics
Tissue Malignancy Treatments
Topical Adminstration Technology
Transdermal Estrogen Patch
Tropical Plants
Ultrasound Contrast Agent
Vaccine Research
Vaccines, gene-based
Virus Prevention and Treatment - Coronavirus
Virus Vaccines
Wart Removal Products
Water-Jel Sterile Burn Dressings
Yeast-based Screening Technology
For more information about this report visit https://www.researchandmarkets.com/r/pzkde1
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900